MX9203787A - Composicion farmaceutica que contiene un portador farmaceuticamente adecuado y el compuesto que contiene la estructura (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-ona. - Google Patents

Composicion farmaceutica que contiene un portador farmaceuticamente adecuado y el compuesto que contiene la estructura (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-ona.

Info

Publication number
MX9203787A
MX9203787A MX9203787A MX9203787A MX9203787A MX 9203787 A MX9203787 A MX 9203787A MX 9203787 A MX9203787 A MX 9203787A MX 9203787 A MX9203787 A MX 9203787A MX 9203787 A MX9203787 A MX 9203787A
Authority
MX
Mexico
Prior art keywords
alpha
pregn
methyl
pharmaceutical composition
hidroxi
Prior art date
Application number
MX9203787A
Other languages
English (en)
Inventor
Gerard Arnoud Jozef Maria Sas
Emili Martin Van Doornum
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19854317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9203787(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of MX9203787A publication Critical patent/MX9203787A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX9203787A 1989-03-18 1992-06-29 Composicion farmaceutica que contiene un portador farmaceuticamente adecuado y el compuesto que contiene la estructura (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-ona. MX9203787A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8900673 1989-03-18

Publications (1)

Publication Number Publication Date
MX9203787A true MX9203787A (es) 1992-07-01

Family

ID=19854317

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203787A MX9203787A (es) 1989-03-18 1992-06-29 Composicion farmaceutica que contiene un portador farmaceuticamente adecuado y el compuesto que contiene la estructura (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-ona.

Country Status (17)

Country Link
US (1) US5037817A (es)
EP (1) EP0389035B1 (es)
JP (2) JP3139709B2 (es)
KR (1) KR0183401B1 (es)
AT (1) ATE98490T1 (es)
AU (1) AU625083B2 (es)
CA (1) CA2011452C (es)
DE (1) DE69005165T2 (es)
DK (1) DK0389035T3 (es)
ES (1) ES2062292T3 (es)
FI (1) FI94865C (es)
HK (1) HK1002019A1 (es)
IE (1) IE63051B1 (es)
MX (1) MX9203787A (es)
NZ (1) NZ232946A (es)
PT (1) PT93488B (es)
ZA (1) ZA901674B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2116829C (en) * 1993-03-05 2004-09-14 Godefridus Hermanus Johanna Deckers Use of a pregnane derivative
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
IL123984A (en) 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
CN100378116C (zh) * 1998-10-16 2008-04-02 欧加农股份有限公司 包含(7α,17α)-17-羟基-7-甲基-19-去甲-17-孕-5(10)-烯-20-炔-3-酮的高纯度组合物
US7045513B1 (en) 1999-03-18 2006-05-16 Genelabs Technologies, Inc. DHEA composition and method
CN100544726C (zh) * 1999-03-18 2009-09-30 基因实验室技术公司 Dhea制剂及方法
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
ATE364619T1 (de) * 2001-10-18 2007-07-15 Norton Healthcare Ltd Tibolonformulierungen
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
KR20040073572A (ko) * 2002-01-22 2004-08-19 악조 노벨 엔.브이. 내인성 에스트로겐의 합성을 예방하는 약물의 투여와관련된 호소 증상의 치료에서의 티볼론
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
CN1324041C (zh) * 2003-04-01 2007-07-04 上海迪赛诺医药科技开发有限公司 替勃龙晶型i的制备方法
US20060134191A1 (en) * 2003-05-23 2006-06-22 Pieter De Haan Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
WO2006125453A1 (en) * 2005-05-23 2006-11-30 Newchem S.P.A. Process for the preparation of pure crystalline tibolone
EP1821571A1 (en) * 2006-02-15 2007-08-22 Oticon A/S Loop antenna for in the ear audio device
ITMI20130120A1 (it) * 2013-01-25 2014-07-26 Ind Chimica Srl Processo per la preparazione in forma cristallina di tibolone, (7alfa,17alfa)-17-idrossi-7-metil-19-norpregn-5(10)-en-20-in-3-one
DK3452019T3 (da) 2016-05-04 2021-09-06 Novalon S A Anvendelse af sukkeralkoholer i tibolonsammensætninger

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (es) * 1964-06-16
US4933168A (en) * 1975-05-27 1990-06-12 Syntex Pharmaceuticals International Limited Stable, crystalline flunisolide
US4273710A (en) * 1979-05-21 1981-06-16 Syntex Corporation Process for preparing flunisolide
US4391755A (en) * 1982-01-18 1983-07-05 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
US4447426A (en) * 1982-01-18 1984-05-08 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators

Also Published As

Publication number Publication date
CA2011452A1 (en) 1990-09-18
DE69005165D1 (de) 1994-01-27
ES2062292T3 (es) 1994-12-16
EP0389035A1 (en) 1990-09-26
DK0389035T3 (da) 1994-02-14
PT93488A (pt) 1990-11-07
JPH0347195A (ja) 1991-02-28
PT93488B (pt) 1996-02-29
JP2001139473A (ja) 2001-05-22
FI94865B (fi) 1995-07-31
KR0183401B1 (ko) 1999-05-01
FI94865C (fi) 1995-11-10
EP0389035B1 (en) 1993-12-15
IE63051B1 (en) 1995-03-22
IE900709L (en) 1990-09-18
US5037817A (en) 1991-08-06
KR900013950A (ko) 1990-10-22
JP3139709B2 (ja) 2001-03-05
AU625083B2 (en) 1992-07-02
AU5139490A (en) 1990-09-20
FI901328A0 (fi) 1990-03-16
ATE98490T1 (de) 1994-01-15
ZA901674B (en) 1990-12-28
HK1002019A1 (en) 1998-07-24
CA2011452C (en) 1999-05-25
DE69005165T2 (de) 1994-05-05
NZ232946A (en) 1991-08-27

Similar Documents

Publication Publication Date Title
MX9203787A (es) Composicion farmaceutica que contiene un portador farmaceuticamente adecuado y el compuesto que contiene la estructura (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-ona.
LV5749B4 (lv) Farmaceitiska kompozicija kas satur ciklosporinus
SE8600017D0 (sv) New compound
ATE78166T1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
ES2085898T3 (es) Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
IT8819731A0 (it) Composizioni farmaceutiche contenenti timosina alfa 1.
ES297099Y (es) Divisional del m. utilidad 296950 solicitado el 9-6-86
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
IT1224250B (it) Associzione del depiprazolo con la morfina
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
ATE81002T1 (de) Fixe arzneimittelkombination mit verzoegerter freisetzung.
IT1217837B (it) Procedimento per la preparazione del "alfa /4(1,1 dimetiletil)fenil/piperidinbutanolo"
ES2072090T3 (es) Derivados maleimidicos que contienen residuos acrilicos.
DE59207579D1 (de) Zusammensetzungen enthaltend mit Phosphonatgruppen substituierte N-Heterozyklen mit 6 Ringgliedern
ES555408A0 (es) Mejoras introducidas en el objeto de la patente principal n.532250 por:perfeccionamientos introducidas en un lapiz de labios giratorio.
MX9207389A (es) Entrega transdermica de activadores cognoscitivos para el mejoramiento de la memoria.
IT8921095A0 (it) Composizione per l'aumento del guadagno di peso.
FR2575070B3 (fr) Composition a effet assainissant, en particulier pour le parfumage d'air ambiant
IT8820059A0 (it) Apparecchio per illuminazione astruttura modulare, utilizzabile singolarmente od in piu' esemplari, variamente accoppiabili.
ES556915A0 (es) Mejoras en el objeto de la pat. principal n. 553.966 por perfeccionamientos introducidos en la construccion de ventiladores helicoidales.
ES1006468Y (es) Pasamuros retenedor perfeccionado.
IT8624347V0 (it) Dispositivo per l'alimentazione di lampade a scarica.
ITPE920009U3 (it) "supporto o gamba per scrivania operativa"
ES554226A0 (es) Merjoras en el objeto de la patente principal n 548.447 por prefeccionamientos en la construccion de pantografos mecanicos